Back
Lantronix, Inc. 10K Form
Sell
50
LTRX
Lantronix, Inc.
Last Price:
$5.58
Seasonality Move:
10.45%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-02 | 10Q | LTRX/Lantronix, Inc. Quarterly |
| 2024-02-08 | 10Q | LTRX/Lantronix, Inc. Quarterly |
| 2023-11-08 | 10Q | LTRX/Lantronix, Inc. Quarterly |
| 2023-05-10 | 10Q | LTRX/Lantronix, Inc. Quarterly |
| 2023-02-09 | 10Q | LTRX/Lantronix, Inc. Quarterly |
| 2022-11-09 | 10Q | LTRX/Lantronix, Inc. Quarterly |
Receive LTRX News And Ratings
See the #1 stock for the next 7 days that we like better than LTRX
LTRX Financial Statistics
Sales & Book Value
| Annual Sales: | $122.9M |
|---|---|
| Cash Flow: | $3.5M |
| Price / Cash Flow: | 28.01 |
| Annual Sales: | $1.90 |
| Price / Book: | 2.97 |
Profitability
| EPS (TTM): | -0.26420 |
|---|---|
| Net Income (TTM): | $-10.3M |
| Gross Margin: | $46.6M |
| Return on Equity: | -13.48% |
| Return on Assets: | -8.03% |
Lantronix, Inc. Earnings Forecast
Key Lantronix, Inc. Financial Ratios
-
The Gross Profit Margin over the past 27 years for LTRX is 37.92%.
-
The Selling, General & Administrative Expenses for LTRX have been equal to 29.49% of Gross Profit Margin.
-
The Research & Development expenses have been 15.13% of Revenue.
-
The Net Earning history of LTRX is -9.25% of Total Revenues.
-
Per Share Earnings over the last 27 years have been positive in 14 years.
Lantronix, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Communications Equipment |
| Sector: | Information Technology |
| Current Symbol: | LTRX |
| CUSIP: | 516548 |
| Website: | lantronix.com |
Debt
| Debt-to-Equity Ratio: | 0.27 |
|---|---|
| Current Ratio: | 3.01 |
| Quick Ratio: | 1.8 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 17.03 |
LTRX Technical Analysis vs Fundamental Analysis
Sell
50
Lantronix, Inc. (LTRX)
is a Sell
Is Lantronix, Inc. a Buy or a Sell?
-
Lantronix, Inc. stock is rated a SellThe current Lantronix, Inc. [LTRX] share price is $5.62. The Score for LTRX is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.